about
Inhibrx Inc is a clinical-stage biotechnology company focused on developing a pipeline of novel biologic therapeutic candidates. It combines an understanding of target biology with protein engineering, proprietary discovery technologies, and an integ...
Read More
80.69
-0.30
(-0.37%)
196.7K
XNAS Volume
XNAS 07 Nov, 2025 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Bullish
Inhibrx Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..